Andere Sprachen NanoRepro AG

Aktien

Realtime-Estimate Tradegate Andere Börsenplätze 13:30:00 23.04.2024			% 5 Tage	% 1. Jan.
1.73 ^EUR	0.00%		-5.56%	-14.79%

2023	NanoRepro AG meldet Ergebnis für das Halbjahr bis 30. Juni 2023	CI
2023	Die NanoRepro AG (XTRA:NN6) beginnt im Rahmen der am 29. April 2022 erteilten Ermächtigung mit einem Aktienrückkaufprogramm über 10% des ausgegebenen Aktienkapitals.	CI

NanoRepro AG Reports Earnings Results for the Half Year Ended June 30, 2023	31.10.23
DD: NanoRepro AG: Lisa Jüngst, buy	04.08.23
DD: NanoRepro AG: Dr. Olaf Stiller, buy	02.08.23
DD: NanoRepro AG: Dr. Olaf Stiller, buy	02.08.23
DD: NanoRepro AG: Johanna Stiller, buy	02.08.23
NanoRepro AG commences an Equity Buyback Plan for 10% of its issued share capital, under the authorization approved on April 29, 2022.	22.05.23
DD: NanoRepro AG: Lisa Jüngst, buy	17.05.23
DD: NanoRepro AG: Lisa Jüngst, buy	17.05.23
DD: NanoRepro AG: Dr. Olaf Stiller, buy	16.05.23
NanoRepro AG Reports Earnings Results for the Full Year Ended December 31, 2022	04.05.23
NanoRepro AG Reports Earnings Results for the Half Year Ended June 30, 2022	27.09.22
NanoRepro AG Reports Earnings Results for the Full Year Ended December 31, 2021	13.06.22
NanoRepro to Supply 41 Million Rapid COVID-19 Antigen Tests to Viromed	24.11.21
NanoRepro AG Reports Earnings Results for the Half Year Ended June 30, 2021	23.09.21
NanoRepro : Germany Medical Test Kit Maker Eyes SADC Market	30.06.21
NanoRepro : Secures CE Mark on Two SARS-CoV-2 Tests	14.06.21
Nanorepro Ag Reports Earnings Results for the Full Year Ended December 31, 2020	21.05.21
NanoRepro AG : Notification and public disclosure of transactions by persons	22.10.20
NanoRepro AG : Notification and public disclosure of transactions by persons	22.10.20
NanoRepro AG : Notification and public disclosure of transactions by persons	22.10.20

Keine Ergebnisse zu dieser Suche